LMB’s Kiyoshi Nagai looks back on his research on the spliceosome, RNA-protein interactions and the RNA recognition motif, U1A protein, for RNA journal. More…
LMB In The News
British biotech Heptares snapped up by Japan’s Sosei in $400m deal
The Telegraph reports that the LMB spin-out company Heptares has been acquired by Japanese pharmaceutical company Soseito. The group’s research and development activities and 72 employees will remain in Hertfordshire, and Heptares will operate as an autonomous subsidiary to Sosei. Heptares is developing a string of drugs using a technology which can determine the precise […]
Lab land: architectural portrait of LMB
Architectural photographer, David Porter, explores LMB for Cambridge Business magazine, pages 65-69. More…
DNA Sequencing technique featured on Royal Mail stamp
The DNA Sequencing technique, developed by Fred Sanger at the MRC Laboratory of Molecular Biology, is highlighted as one of eight key inventions of the past century, on a new set of stamps, ‘Inventive Britain’ from the Royal Mail. This article is no longer available from the source website: Royal Mail News 19 February 2015
Basic research could lead to fertility improvements, says LMB’s Melina Schuh
The Cambridge News highlights Melina Schuh’s work on the development of mammalian oocytes into fertilisable eggs. Errors during this process are common causes of miscarriages and genetic defects such as Down’s syndrome. This article is no longer available from the source website: Cambridge News 17 February 2015
Venki Ramakrishnan at World Economic Forum in Davos
The end of the antibiotic age? The LMB’s Venki Ramakrishnan took part in a panel discussion on the problem of antibiotic resistance at the World Economic Forum in Davos. In an interview with Katia Moskvitch, he tells us about the importance of gaining a better understanding of the use and misuse of these drugs. More…